ESID
  • Users Online: 298
  • Print this page
  • Email this page

  Reader Comments

Year : 2018 | Volume:  1 | Issue Number:  2

REVIEW ARTICLE

Cardiotoxicity of FDA-approved immune checkpoint inhibitors: A rare but serious adverse event

Zarifa Abdulrazzak, Salih Mohammed, Lopez-Mattei Juan, Lee Hun Ju, Iliescu Cezar, Hassan Saamir, Palaskas Nicolas, Durand Jean-Bernard, Mouhayar Elie, Kim Joseph, Kim Peter

Add Your Comments
 
No one has added comments on this article. Click here to add your remarks


 

Back To Article
CALL FOR PAPERS
Special issue 2019